The raised guidance and expanding margins (Adjusted EBITDA margin 48%) reinforce the durable growth narrative. Traders should watch for continued HSA account growth and custodial revenue trends in the second half, as the company enters a seasonally stronger period. The $948.4M remaining buyback authorization provides downside support.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 27 $93.39entry
- T+1 · 3mo ago +3.19%α +3.42% · $96.37
- T+5 · 3mo ago +5.77%α +5.50% · $98.78
- T+20 · 8w ago −5.13%α −4.62% · $88.60
- T+56 · todayOpen
- T+60 · in 3d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HealthEquity reported Q2 FY2027 revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, beating consensus estimates of $349.2M and $1.19 respectively. The company raised its full-year revenue guidance to $1.411B-$1.421B and non-GAAP EPS to $4.66-$4.73, driven by record HSA accounts (10.7M) and assets ($37.9B), with Adjusted EBITDA margin expanding to 48%. The beat and raised guidance signal strong operational momentum and durable growth in the HSA business.
Key Financial Metrics
Key Facts
- Revenue of $350.7M (+8% YoY) beat consensus of $349.2M
- Non-GAAP EPS of $1.24 beat consensus of $1.19 by 4.2%
- GAAP net income of $65.6M (+10% YoY), GAAP diluted EPS $0.78 (+15% YoY)
- Adjusted EBITDA of $167.0M (+11% YoY), margin expanded to 48% from 46%
- Total HSA Assets grew 14% to $37.9B; HSA accounts up 8% to 10.7M
- Raised FY2027 guidance: revenue $1.411B-$1.421B, non-GAAP EPS $4.66-$4.73
- Repurchased 1.2M shares for $108.1M in Q2; $948.4M remaining authorization
- Record HSA accounts of 10.7M and record HSA Assets of nearly $38B
Financial Impact
Revenue beat by $1.5M (+0.4%), EPS beat by $0.05 (+4.2%), guidance raised by ~$10M at midpoint
Risk Factors
- Dependence on tax-advantaged HSA regulations which could change
- Interest rate sensitivity on HSA cash yields and custodial revenue
- Integration risks from future acquisitions or portfolio purchases
- Competition from larger financial and benefits administration firms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3351951 |
Track record
20 reports on HQY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
- Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers